Amphastar Pharmaceuticals (AMPH) Other Operating Expenses (2013 - 2026)

Amphastar Pharmaceuticals' Other Operating Expenses history runs 14 years deep, the most recent figure standing at $11.9 million for Q1 2026.

• In Q1 2026, Other Operating Expenses rose 0.51% year-over-year to $11.9 million; the TTM figure through Mar 2026 stood at $38.6 million (down 4.33% YoY), while the FY2025 annual figure was $43.9 million, up 16.09% from the prior year.
• Other Operating Expenses was $11.9 million for Q1 2026 at Amphastar Pharmaceuticals, up from $10.3 million in the prior quarter.
• In the past five years, Other Operating Expenses ranged from a high of $11.9 million in Q1 2026 to a low of $4.8 million in Q3 2022.
• Historically, Other Operating Expenses has averaged $8.2 million across 5 years, with a median of $8.6 million in 2023.
• The sharpest annual moves came in 2023 and 2025: Other Operating Expenses jumped 57.51% in 2023, then sank 46.28% in 2025.
• A 5-year view of Other Operating Expenses shows it stood at $5.5 million in 2022, then surged by 57.51% to $8.6 million in 2023, then grew by 20.94% to $10.4 million in 2024, then declined by 1.39% to $10.3 million in 2025, then advanced by 16.03% to $11.9 million in 2026.
• The last three Other Operating Expenses figures came in at $11.9 million (Q1 2026), $10.3 million (Q4 2025), and $11.5 million (Q3 2025), per Business Quant data.